Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer.

Smyth, J F; Hardcastle, J D; Denton, G; Alderson, D; Grace, R H; Mansi, J L; Yosef, H M; Nordle, O; Lauri, H; Wählby, S

Smyth, J F; Hardcastle, J D; Denton, G; Alderson, D; Grace, R H; Mansi, J L; Yosef, H M; Nordle, O; Lauri, H; Wählby, S.

Affiliation

Smyth JF; Department of Clinical Oncology, Western General Hospital, Edinburgh, UK.

Ann Oncol ; 6(9): 948-9, 1995 Nov.

Article in En | MEDLINE | ID: mdl-8624301

Subject(s)

Antineoplastic Agents/therapeutic use; Colorectal Neoplasms/drug therapy; Fluorouracil/therapeutic use; Nitrosourea Compounds/therapeutic use; Taurine/analogs & derivatives; Aged; Antineoplastic Agents/administration & dosage; Colorectal Neoplasms/pathology; Female; Fluorouracil/administration & dosage; Humans; Male; Middle Aged; Nitrosourea Compounds/administration & dosage; Nitrosourea Compounds/adverse effects; Prognosis; Quality of Life; Regression Analysis; Survival Rate; Taurine/administration & dosage; Taurine/adverse effects; Taurine/therapeutic use; Treatment Failure

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Taurine / Colorectal Neoplasms / Fluorouracil / Antineoplastic Agents / Nitrosourea Compounds Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Aspects: Patient_preference Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 1995 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links